| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,497 |
11,741 |
$424K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,504 |
5,585 |
$133K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,466 |
5,247 |
$59K |
| 80305 |
|
12,675 |
8,381 |
$53K |
| 99233 |
Prolong inpt eval add15 m |
2,813 |
933 |
$40K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,900 |
2,439 |
$38K |
| 95816 |
|
830 |
292 |
$25K |
| 99406 |
|
5,879 |
3,664 |
$21K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,742 |
1,623 |
$21K |
| 20610 |
|
1,057 |
635 |
$18K |
| 96112 |
|
697 |
247 |
$18K |
| 93000 |
|
2,609 |
1,755 |
$17K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,720 |
502 |
$17K |
| 99223 |
Prolong inpt eval add15 m |
404 |
307 |
$14K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
232 |
161 |
$11K |
| 93975 |
|
129 |
88 |
$10K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
578 |
435 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
588 |
426 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
1,055 |
698 |
$8K |
| 82947 |
|
7,440 |
4,645 |
$7K |
| 92567 |
|
1,612 |
1,096 |
$6K |
| 99497 |
|
238 |
182 |
$5K |
| 95957 |
|
168 |
69 |
$5K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
492 |
473 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,051 |
721 |
$4K |
| 90688 |
|
733 |
464 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
780 |
520 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,919 |
1,157 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
6,811 |
4,490 |
$4K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
51 |
12 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
125 |
83 |
$4K |
| 27369 |
|
55 |
14 |
$3K |
| 90756 |
|
296 |
193 |
$3K |
| 99173 |
|
1,432 |
994 |
$3K |
| 77002 |
|
148 |
54 |
$3K |
| 77080 |
|
170 |
103 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
283 |
197 |
$2K |
| 90732 |
|
40 |
28 |
$2K |
| 81003 |
|
4,674 |
3,068 |
$2K |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
352 |
253 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,450 |
2,781 |
$1K |
| 95923 |
|
94 |
55 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
311 |
128 |
$1K |
| 80053 |
Comprehensive metabolic panel |
1,092 |
658 |
$1K |
| 97129 |
|
463 |
150 |
$990.26 |
| 93925 |
|
25 |
15 |
$935.70 |
| 82948 |
|
1,625 |
945 |
$927.06 |
| 82962 |
|
1,290 |
900 |
$924.88 |
| 94010 |
|
155 |
87 |
$908.66 |
| 99407 |
|
180 |
119 |
$888.59 |
| 90686 |
|
142 |
120 |
$819.60 |
| 93978 |
|
29 |
16 |
$818.35 |
| 99215 |
Prolong outpt/office vis |
39 |
25 |
$782.50 |
| 93922 |
|
50 |
31 |
$769.58 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,053 |
688 |
$750.17 |
| 80061 |
Lipid panel |
595 |
381 |
$714.18 |
| 90674 |
|
59 |
50 |
$708.26 |
| 99490 |
Ccm add 20min |
118 |
111 |
$703.17 |
| 51798 |
|
165 |
112 |
$658.31 |
| 76775 |
|
48 |
28 |
$646.35 |
| 3008F |
|
775 |
473 |
$580.00 |
| 94375 |
|
69 |
42 |
$572.39 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
139 |
103 |
$513.81 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
603 |
385 |
$407.85 |
| 90658 |
|
46 |
38 |
$355.56 |
| 93923 |
|
25 |
15 |
$353.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,667 |
1,734 |
$306.45 |
| 82043 |
|
200 |
137 |
$238.59 |
| 73560 |
|
31 |
15 |
$231.74 |
| 99217 |
|
15 |
13 |
$226.97 |
| G0008 |
Administration of influenza virus vaccine |
743 |
539 |
$207.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
27 |
$203.83 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
286 |
195 |
$181.05 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
323 |
201 |
$157.68 |
| 99487 |
Ccm add 20min |
107 |
107 |
$128.33 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
215 |
105 |
$122.02 |
| 96127 |
|
70 |
42 |
$111.15 |
| 95921 |
|
25 |
16 |
$98.24 |
| 3077F |
|
1,026 |
584 |
$90.00 |
| 3080F |
|
630 |
364 |
$70.00 |
| 3044F |
|
21 |
17 |
$60.00 |
| 99307 |
|
24 |
24 |
$54.50 |
| 3078F |
|
756 |
465 |
$50.00 |
| 3074F |
|
703 |
439 |
$50.00 |
| 99454 |
|
14 |
14 |
$48.92 |
| 81025 |
|
16 |
12 |
$47.75 |
| 99457 |
|
28 |
27 |
$44.48 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
52 |
26 |
$42.11 |
| 3079F |
|
615 |
389 |
$40.02 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
45 |
25 |
$34.54 |
| 1111F |
|
50 |
41 |
$30.00 |
| G0009 |
Administration of pneumococcal vaccine |
58 |
38 |
$22.65 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
19 |
14 |
$21.96 |
| 90901 |
|
484 |
154 |
$20.66 |
| 3075F |
|
219 |
148 |
$20.02 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
61 |
33 |
$4.41 |
| 94760 |
|
23 |
12 |
$3.70 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
369 |
215 |
$0.11 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
934 |
536 |
$0.02 |
| 1160F |
|
519 |
351 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
152 |
123 |
$0.00 |
| 1159F |
|
639 |
424 |
$0.00 |
| 1124F |
|
25 |
16 |
$0.00 |
| 4274F |
|
22 |
15 |
$0.00 |
| M1208 |
Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety |
198 |
146 |
$0.00 |
| 1125F |
|
603 |
403 |
$0.00 |
| 1123F |
|
209 |
149 |
$0.00 |
| 1170F |
|
454 |
313 |
$0.00 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
111 |
70 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
67 |
52 |
$0.00 |
| 3048F |
|
51 |
34 |
$0.00 |